Journal of the American Society of Nephrology
A Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted
Computational studyInterventions
Papers by Nikolaus Marx
9 results
- American Heart Journal
Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3)
Trial in 7,076 peopleCardiovascular disease - European Journal of Internal Medicine
Innovative holistic treatment for CKM: what lies ahead?
ReviewInterventions - Biomedicine & Pharmacotherapy
Development of a monoclonal antibody targeting the calcification blocking factor CBF
Cohort study in peopleVascular calcification
- Europace
Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration
Meta-analysis of observational studiesAtrial fibrillation - Nature Reviews Nephrology
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes
ReviewInterventions - ADA Scientific Sessions 2026 Abstract
Effect of Subcutaneous Semaglutide on Cardiorenal Outcomes across Type 2 Diabetes Subtypes: SUSTAIN 6 Post Hoc Analysis
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Oral Semaglutide and Cardiovascular Outcomes by Baseline A1C and BMI in People with Type 2 Diabetes in the SOUL Trial
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Prediabetes Remission and Cardiovascular Mortality and Morbidity
Trial in peopleInterventions